Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMC 1523185)

Published in EMBO J on July 26, 2006

Authors

Lina Williamson1, Natalia A Raess, Reto Caldelari, Anthony Zakher, Alain de Bruin, Horst Posthaus, Reinhard Bolli, Thomas Hunziker, Maja M Suter, Eliane J Müller

Author Affiliations

1: Molecular Dermatology, Institute Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Articles citing this

MYC in mammalian epidermis: how can an oncogene stimulate differentiation? Nat Rev Cancer (2008) 1.78

The desmosome. Cold Spring Harb Perspect Biol (2009) 1.77

Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol (2009) 1.73

The desmosome and pemphigus. Histochem Cell Biol (2008) 1.54

Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J Biol Chem (2008) 1.43

Desmosomes: new perpetrators in tumour suppression. Nat Rev Cancer (2011) 1.33

Desmoglein as a target in skin disease and beyond. J Invest Dermatol (2011) 1.28

Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell (2007) 1.27

Pemphigus autoimmunity: hypotheses and realities. Autoimmunity (2011) 1.23

Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling. Mol Cell Biol (2011) 1.17

Plakoglobin: role in tumorigenesis and metastasis. Int J Cell Biol (2012) 1.15

Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. J Invest Dermatol (2009) 1.13

The biology of the desmosome-like junction a versatile anchoring junction and signal transducer in the seminiferous epithelium. Int Rev Cell Mol Biol (2011) 1.12

p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis. J Biol Chem (2010) 1.12

Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies. J Invest Dermatol (2008) 1.05

Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3. J Invest Dermatol (2010) 1.03

Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3. Am J Pathol (2007) 1.00

Structure, function, and regulation of desmosomes. Prog Mol Biol Transl Sci (2013) 1.00

Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering. J Clin Invest (2013) 0.99

Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation. PLoS One (2012) 0.99

Plakoglobin rescues adhesive defects induced by ectodomain truncation of the desmosomal cadherin desmoglein 1: implications for exfoliative toxin-mediated skin blistering. Am J Pathol (2010) 0.95

Desmosomes: just cell adhesion or is there more? Cell Adh Migr (2007) 0.94

Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor. Am J Pathol (2009) 0.93

DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway. PLoS One (2013) 0.92

Desmoglein 3, via an interaction with E-cadherin, is associated with activation of Src. PLoS One (2010) 0.92

Nuclear signaling from cadherin adhesion complexes. Curr Top Dev Biol (2015) 0.90

MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris. J Invest Dermatol (2013) 0.90

Beyond cell adhesion: the role of armadillo proteins in the heart. Cell Signal (2012) 0.89

Desmoglein 3: a help or a hindrance in cancer progression? Cancers (Basel) (2015) 0.87

Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity. J Autoimmun (2008) 0.86

Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus. J Biol Chem (2009) 0.86

Post-translational control of Myc function during differentiation. Cell Cycle (2011) 0.85

Transcriptional and functional differences in stem cell populations isolated from extraocular and limb muscles. Physiol Genomics (2008) 0.83

Experimental human cell and tissue models of pemphigus. Dermatol Res Pract (2010) 0.83

Desmosomes in acquired disease. Cell Tissue Res (2015) 0.83

Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin. J Immunol (2009) 0.82

Mouse models for blistering skin disorders. Dermatol Res Pract (2010) 0.81

Plakoglobin as a regulator of desmocollin gene expression. J Invest Dermatol (2013) 0.81

A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis. J Biol Chem (2013) 0.81

An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris. J Invest Dermatol (2011) 0.81

Superficial dsg2 expression limits epidermal blister formation mediated by pemphigus foliaceus antibodies and exfoliative toxins. Dermatol Res Pract (2010) 0.81

Analysis of a Jup hypomorphic allele reveals a critical threshold for postnatal viability. Genesis (2012) 0.80

Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion. PLoS One (2013) 0.80

Plakoglobin but not desmoplakin regulates keratinocyte cohesion via modulation of p38MAPK signaling. J Invest Dermatol (2014) 0.80

Apoptotic pathways in pemphigus. Dermatol Res Pract (2010) 0.79

The role of intracellular protein O-glycosylation in cell adhesion and disease. J Biomed Res (2011) 0.77

Desmoglein 2 compensates for desmoglein 3 but does not control cell adhesion via regulation of p38 mitogen-activated protein kinase in keratinocytes. J Biol Chem (2014) 0.77

Immune response in pemphigus and beyond: progresses and emerging concepts. Semin Immunopathol (2015) 0.77

Cell adhesion in epidermal development and barrier formation. Curr Top Dev Biol (2015) 0.77

Mechanisms of Autoantibody-Induced Pathology. Front Immunol (2017) 0.76

Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53. PLoS One (2016) 0.76

Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris. PLoS One (2015) 0.75

A new light on an old disease: adhesion signaling in pemphigus vulgaris. J Invest Dermatol (2014) 0.75

The physical interaction of p53 and plakoglobin is necessary for their synergistic inhibition of migration and invasion. Oncotarget (2016) 0.75

A novel method to investigate pemphigus-induced keratinocyte dysmorphisms through living cell immunofluorescence microscopy. Virchows Arch (2007) 0.75

Articles cited by this

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (1999) 20.34

beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J (1997) 12.97

XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell (1996) 11.70

Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev (2001) 6.36

LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]. Genes Dev (1991) 5.95

LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development (2005) 5.80

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol (2000) 5.55

Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev (1996) 5.13

Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell (1999) 4.38

DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING. Proc Soc Exp Biol Med (1964) 3.73

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A (2004) 3.60

Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell (1991) 3.42

Stem cell depletion through epidermal deletion of Rac1. Science (2005) 3.26

The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest (2002) 3.23

c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr Biol (2001) 3.22

Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09

Deregulated expression of c-Myc depletes epidermal stem cells. Nat Genet (2001) 3.00

Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours. Development (2002) 2.79

Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer (2003) 2.69

The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev (1996) 2.61

Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene (2003) 2.57

c-Myc promotes differentiation of human epidermal stem cells. Genes Dev (1997) 2.37

Plakoglobin and beta-catenin: protein interactions, regulation and biological roles. J Cell Sci (2000) 2.32

Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment. Development (2003) 2.23

Functional characterization of multiple transactivating elements in beta-catenin, some of which interact with the TATA-binding protein in vitro. J Biol Chem (1999) 1.98

Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol (2004) 1.96

Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin. Mol Cell Biol (2000) 1.93

gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev (2000) 1.89

Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest (1999) 1.87

Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol (2003) 1.80

Desmoglein 3 anchors telogen hair in the follicle. J Cell Sci (1998) 1.77

Stem cell fate and patterning in mammalian epidermis. Curr Opin Genet Dev (2001) 1.53

A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol (2001) 1.43

Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem (2005) 1.42

The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc Natl Acad Sci U S A (1995) 1.34

Desmosomes and disease: pemphigus and bullous impetigo. Curr Opin Cell Biol (2004) 1.33

Plakoglobin suppresses epithelial proliferation and hair growth in vivo. J Cell Biol (2000) 1.30

Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms. Proc Natl Acad Sci U S A (2005) 1.29

Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. J Invest Dermatol (1998) 1.28

Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol (1999) 1.27

Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J (2001) 1.19

Proliferation, cell cycle exit, and onset of terminal differentiation in cultured keratinocytes: pre-programmed pathways in control of C-Myc and Notch1 prevail over extracellular calcium signals. J Invest Dermatol (2005) 1.18

Activation of Rac by cadherin through the c-Src-Rap1-phosphatidylinositol 3-kinase-Vav2 pathway. Oncogene (2006) 1.17

Mechanisms of plakoglobin-dependent adhesion: desmosome-specific functions in assembly and regulation by epidermal growth factor receptor. J Biol Chem (2005) 1.15

Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab Invest (2000) 1.09

beta-Catenin is not required for proliferation and differentiation of epidermal mouse keratinocytes. J Cell Sci (2002) 1.09

Desmosomal proteins, including desmoglein 3, serve as novel negative markers for epidermal stem cell-containing population of keratinocytes. J Cell Sci (2003) 1.09

Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis. Oncogene (1999) 1.04

Axin directly interacts with plakoglobin and regulates its stability. J Biol Chem (1999) 1.03

beta-catenin-dependent and -independent effects of DeltaN-plakoglobin on epidermal growth and differentiation. Mol Cell Biol (2004) 0.92

Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents. Carcinogenesis (2002) 0.86

Comparison of growth and differentiation of normal and neoplastic canine keratinocyte cultures. Vet Pathol (1991) 0.83

Role of mitochondria in tributyltin-induced interleukin-1alpha production in murine keratinocytes. J Invest Dermatol (1996) 0.78

Autoimmune pemphigus. A distinct staining pattern with an anti-desmoglein antibody. Arch Dermatol (1993) 0.77

"Eczema" revisited. A status report based upon current textbooks of dermatology. Am J Dermatopathol (1994) 0.77

Articles by these authors

Extra-embryonic function of Rb is essential for embryonic development and viability. Nature (2003) 3.92

Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res (2008) 3.41

Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell (2008) 2.61

Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol (2003) 1.95

Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. J Biol Chem (2005) 1.95

Rb is critical in a mammalian tissue stem cell population. Genes Dev (2007) 1.92

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol (2010) 1.74

The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. J Biol Chem (2008) 1.67

Consequences of depleted SERCA2-gated calcium stores in the skin. J Invest Dermatol (2006) 1.53

Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ (2002) 1.51

Mouse development with a single E2F activator. Nature (2008) 1.51

Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation? J Invest Dermatol (2008) 1.50

An autologous epidermal equivalent tissue-engineered from follicular outer root sheath keratinocytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcers. Wound Repair Regen (2003) 1.49

High-dose intravenous corticosteroid pulse therapy in alopecia areata: own experience compared with the literature. J Dtsch Dermatol Ges (2008) 1.48

Essential role for survivin in early brain development. J Neurosci (2005) 1.44

EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship. Exp Dermatol (2014) 1.41

E2F8 is essential for polyploidization in mammalian cells. Nat Cell Biol (2012) 1.39

Atypical E2F repressors and activators coordinate placental development. Dev Cell (2012) 1.33

Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms. Proc Natl Acad Sci U S A (2005) 1.29

E2F7 represses a network of oscillating cell cycle genes to control S-phase progression. Nucleic Acids Res (2011) 1.26

Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology (2008) 1.19

Proliferation, cell cycle exit, and onset of terminal differentiation in cultured keratinocytes: pre-programmed pathways in control of C-Myc and Notch1 prevail over extracellular calcium signals. J Invest Dermatol (2005) 1.18

Physiological significance of polyploidization in mammalian cells. Trends Cell Biol (2013) 1.16

Mechanisms of plakoglobin-dependent adhesion: desmosome-specific functions in assembly and regulation by epidermal growth factor receptor. J Biol Chem (2005) 1.15

Large induction of type III deiodinase expression after partial hepatectomy in the regenerating mouse and rat liver. Endocrinology (2008) 1.12

beta-Catenin is not required for proliferation and differentiation of epidermal mouse keratinocytes. J Cell Sci (2002) 1.09

E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1. EMBO J (2012) 1.09

The metalloprotease meprinbeta processes E-cadherin and weakens intercellular adhesion. PLoS One (2008) 1.07

Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence. Cancer Res (2010) 1.05

Wound stimulation by growth-arrested human keratinocytes and fibroblasts: HP802-247, a new-generation allogeneic tissue engineering product. Dermatology (2010) 1.01

Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level. Blood (2003) 1.00

Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma. Dermatology (2009) 0.98

Plakoglobin is required for effective intermediate filament anchorage to desmosomes. J Invest Dermatol (2008) 0.97

Exogenous nitric oxide triggers Neospora caninum tachyzoite-to-bradyzoite stage conversion in murine epidermal keratinocyte cell cultures. Int J Parasitol (2002) 0.97

Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment. J Allergy Clin Immunol (2005) 0.97

Clostridium perfringens beta-toxin induces necrostatin-inhibitable, calpain-dependent necrosis in primary porcine endothelial cells. PLoS One (2013) 0.97

Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol (2002) 0.96

In vivo biocompatibility and biodegradation of 3D-printed porous scaffolds based on a hydroxyl-functionalized poly(ε-caprolactone). Biomaterials (2012) 0.95

Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease. Aging (Albany NY) (2014) 0.95

Lack of DNA mismatch repair protein MSH6 in the rat results in hereditary non-polyposis colorectal cancer-like tumorigenesis. Carcinogenesis (2008) 0.94

Rapid cytopathic effects of Clostridium perfringens beta-toxin on porcine endothelial cells. Infect Immun (2010) 0.94

BP230- and BP180-specific auto-antibodies in bullous pemphigoid. J Invest Dermatol (2004) 0.94

Homozygous and heterozygous p53 knockout rats develop metastasizing sarcomas with high frequency. Am J Pathol (2011) 0.93

Missing C-terminal filaggrin expression, NFkappaB activation and hyperproliferation identify the dog as a putative model to study epidermal dysfunction in atopic dermatitis. Exp Dermatol (2010) 0.93

The keratinocyte in epidermal renewal and defence. Vet Dermatol (2009) 0.92

Clostridium perfringens beta-toxin binding to vascular endothelial cells in a human case of enteritis necroticans. J Med Microbiol (2009) 0.91

Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. Eur J Dermatol (2006) 0.91

Plakoglobin deficiency protects keratinocytes from apoptosis. J Invest Dermatol (2006) 0.89

A hypomorphic mutation in Lpin1 induces progressively improving neuropathy and lipodystrophy in the rat. J Biol Chem (2011) 0.89

From cell signaling to novel therapeutic concepts: international pemphigus meeting on advances in pemphigus research and therapy. J Invest Dermatol (2010) 0.89

Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model. Hepatology (2013) 0.89

Local tolerance and stability up to 24 months of a new 20% proline-stabilized polyclonal immunoglobulin for subcutaneous administration. Biologicals (2011) 0.88

Deletion of the serotonin transporter in rats disturbs serotonin homeostasis without impairing liver regeneration. Am J Physiol Gastrointest Liver Physiol (2009) 0.88

Isolation and genotyping of Toxoplasma gondii causing fatal systemic toxoplasmosis in an immunocompetent 10-year-old cat. J Vet Diagn Invest (2011) 0.88

Fractional transepidermal delivery: a histological analysis. Dermatology (2011) 0.87

Assessment of melanocytic skin lesions with a high-definition laser Doppler imaging system. Skin Res Technol (2011) 0.87

Atypical E2fs control lymphangiogenesis through transcriptional regulation of Ccbe1 and Flt4. PLoS One (2013) 0.86

Self-reactivity in the dimeric intravenous immunoglobulin fraction. Ann N Y Acad Sci (2007) 0.86

Organotypic cultures of autologous hair follicle keratinocytes for the treatment of recurrent leg ulcers. J Am Acad Dermatol (2003) 0.85

Nuclear survivin expression as a potentially useful tool for the diagnosis of canine cutaneous sebaceous lesions. Vet Dermatol (2012) 0.85

Short- and long-term cultivation of embryonic and neonatal murine keratinocytes. Methods Mol Biol (2010) 0.85

Plakoglobin-dependent disruption of the desmosomal plaque in pemphigus vulgaris. Exp Dermatol (2007) 0.84

A mutation in the SUV39H2 gene in Labrador Retrievers with hereditary nasal parakeratosis (HNPK) provides insights into the epigenetics of keratinocyte differentiation. PLoS Genet (2013) 0.84

Monomerization of dimeric IgG of intravenous immunoglobulin (IVIg) increases the antibody reactivity against intracellular antigens. Mol Immunol (2008) 0.84

Loss of Pten promotes angiogenesis and enhanced vegfaa expression in zebrafish. Dis Model Mech (2013) 0.84

Nuclear c-Myc: a molecular marker for early stage pemphigus vulgaris. J Invest Dermatol (2007) 0.83

The canine hair cycle - a guide for the assessment of morphological and immunohistochemical criteria. Vet Dermatol (2011) 0.83

Haploinsufficiency of the genes encoding the tumor suppressor Pten predisposes zebrafish to hemangiosarcoma. Dis Model Mech (2011) 0.82

A nonsense mutation in the optic atrophy 3 gene (OPA3) causes dilated cardiomyopathy in Red Holstein cattle. Genomics (2010) 0.82

Use of epidermal equivalents generated from follicular outer root sheath cells in vitro and for autologous grafting of chronic wounds. Cells Tissues Organs (2002) 0.82

Is interleukin-4delta3 splice variant expression in bovine tuberculosis a marker of protective immunity? Infect Immun (2007) 0.81

Pulmonary Disease due to Mycobacterium tuberculosis in a Horse: Zoonotic Concerns and Limitations of Antemortem Testing. Vet Med Int (2012) 0.81

An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris. J Invest Dermatol (2011) 0.81

Keratinocyte transcriptional regulation of the human c-Myc promoter occurs via a novel Lef/Tcf binding element distinct from neoplastic cells. FEBS Lett (2007) 0.81

Clinical and histological characterization of hair coat and glandular tissue of Chinese crested dogs. Vet Dermatol (2013) 0.80

E2F Transcription Factors Control the Roller Coaster Ride of Cell Cycle Gene Expression. Methods Mol Biol (2016) 0.80

Causes of mortality in reintroduced Eurasian lynx in Switzerland. J Wildl Dis (2002) 0.80

An imaging workflow for characterizing phenotypical change in large histological mouse model datasets. J Biomed Inform (2008) 0.80

In vitro cell compatibility and antibacterial activity of microencapsulated doxycycline designed for improved localized therapy of septic arthritis. J Antimicrob Chemother (2008) 0.79

Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients. J Pathol (2013) 0.79

Serologic survey in a colony of captive common marmosets (Callithrix jacchus) after infection with herpes simplex type 1-like virus. J Zoo Wildl Med (2004) 0.79

Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study. Dermatology (2003) 0.79

DEVRIESEASIS IN A PLUMED BASILISK (BASILISCUS PLUMIFRONS) AND CHINESE WATER DRAGONS (PHYSIGNATHUS COCINCINUS) IN A ZOOLOGIC COLLECTION. J Zoo Wildl Med (2016) 0.79

Slow release antibiotics for treatment of septic arthritis in large animals. Vet J (2009) 0.78